The safety of CBD in cosmetic applications has been ratified by the top scientific experts of the European Union.
📷 AECANI Visual Lab
Positive Scientific Opinion
The SCCS has evaluated Cannabidiol (CBD) and concluded that its use in cosmetics is safe for consumers under normal recommended conditions of use.
SCCS conclusions
The technical evaluations highlight that:
- The CBD does not present relevant acute toxicity after topical application.
- It has no psychotropic effects, which clearly differentiates it from THC.
- Impurities of THC in CBD products must be kept below trace levels to ensure total safety.
Market Impact
Thanks to these favorable opinions:
The inclusion of CBD in the CosIng database enables European manufacturers to compete in a global wellness market.
📷 AECANI Visual Lab
- CosIng: CBD was included in the EU cosmetic ingredients database.
- Legal certainty: Manufacturers can register their products in the Cosmetic Product Notification Portal (CPNP) with scientific backing.
- Innovation: The development of creams, serums and body oils with CBD has been promoted throughout Europe.
Divergent Proposal
The ANSES (France) proposal to classify CBD presents an interpretation that differs from the technical evaluations of the European SCCS, which opens a relevant methodological debate.
The AECANI Posture
AECANI proposes that national regulations consider the European SCCS evaluations to promote harmonization and competitiveness of the sector.
"Cosmetics with CBD is a safe and dynamic sector that would benefit from a harmonized regulatory framework based on the available scientific evidence.
📚 References
- SCCS/1644/22 - Opinion on Cannabidiol (CBD)
- Regulation (EC) No. 1223/2009 - On cosmetic products